NUCOR CORP Stock Compensation Disclosure
16. Stock-Based Compensation
Overview
The Company maintains the Nucor Corporation 2025 Omnibus Incentive Compensation Plan (the “Omnibus Plan”) under which the Company may award stock-based compensation to employees, officers, consultants and non-employee directors. The Company’s stockholders approved the Omnibus Plan on May 8, 2025. The Omnibus Plan permits the award of stock options, appreciation rights, restricted share units, restricted shares, performance shares and performance units for up to 6.8 million shares of the Company’s common stock. As of December 31, 2025, 6.0 million shares remained available for award under the Omnibus Plan.
The Company also maintains a number of inactive plans, including the Nucor Corporation 2014 Omnibus Incentive Compensation Plan (the "2014 Plan"), under which stock-based awards remain outstanding but no further awards may be made. As of December 31, 2025, 1.6 million shares were reserved for issuance upon the future settlement of outstanding awards under such inactive plans.
Stock Options
Stock options may be granted to employees, officers, consultants and non-employee directors with exercise prices at 100% of the market value on the date of the grant. The stock options granted are generally exercisable at the end of three years and have a term of 10 years.
A summary of activity under Nucor’s stock option plans is as follows (shares in thousands):
|
|
Year Ended December 31, |
|
|||||||||||||||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||||||||||||||
|
|
|
|
|
Weighted- |
|
|
|
|
|
Weighted- |
|
|
|
|
|
Weighted- |
|
||||||
|
|
|
|
|
Average |
|
|
|
|
|
Average |
|
|
|
|
|
Average |
|
||||||
|
|
|
|
|
Exercise |
|
|
|
|
|
Exercise |
|
|
|
|
|
Exercise |
|
||||||
|
|
Shares |
|
|
Price |
|
|
Shares |
|
|
Price |
|
|
Shares |
|
|
Price |
|
||||||
Number of shares under stock options: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Outstanding at beginning of year |
|
|
724 |
|
|
$ |
89.06 |
|
|
|
718 |
|
|
$ |
78.33 |
|
|
|
837 |
|
|
$ |
66.76 |
|
Granted |
|
|
138 |
|
|
$ |
109.36 |
|
|
|
73 |
|
|
$ |
168.85 |
|
|
|
91 |
|
|
$ |
133.03 |
|
Exercised |
|
|
(40 |
) |
|
$ |
120.91 |
|
|
|
(64 |
) |
|
$ |
55.84 |
|
|
|
(210 |
) |
|
$ |
55.85 |
|
Canceled |
|
|
— |
|
|
$ |
— |
|
|
|
(3 |
) |
|
$ |
168.85 |
|
|
|
— |
|
|
$ |
— |
|
Outstanding at end of year |
|
|
822 |
|
|
$ |
90.92 |
|
|
|
724 |
|
|
$ |
89.06 |
|
|
|
718 |
|
|
$ |
78.33 |
|
Stock options exercisable at end of year |
|
|
562 |
|
|
$ |
72.95 |
|
|
|
490 |
|
|
$ |
63.65 |
|
|
|
433 |
|
|
$ |
48.33 |
|
The total intrinsic value of stock options (the amount by which the stock price exceeded the exercise price of the stock option on the date of exercise) that were exercised during 2025 was $1 million ($9 million in 2024 and $25 million in 2023).
The following table summarizes information about stock options outstanding at December 31, 2025 (shares in thousands):
|
|
Options Outstanding |
|
|
Options Exercisable |
|
||||||||||||
|
|
|
|
|
Weighted- |
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
Average |
|
Weighted- |
|
|
|
|
|
Weighted- |
|
||||
Range of |
|
Number |
|
|
Remaining |
|
Average |
|
|
Number |
|
|
Average |
|
||||
Exercise Prices |
|
Outstanding |
|
|
Life |
|
Price |
|
|
Exercisable |
|
|
Price |
|
||||
$40.00 - $70.00 |
|
|
355 |
|
|
4.2 years |
|
$ |
44.06 |
|
|
|
355 |
|
|
$ |
44.06 |
|
$70.01 - $100.00 |
|
|
— |
|
|
0.0 years |
|
$ |
— |
|
|
|
— |
|
|
$ |
— |
|
$100.01 - $130.00 |
|
|
234 |
|
|
7.6 years |
|
$ |
110.00 |
|
|
|
108 |
|
|
$ |
110.74 |
|
$130.01 - $160.00 |
|
|
163 |
|
|
6.9 years |
|
$ |
131.85 |
|
|
|
88 |
|
|
$ |
130.84 |
|
$160.01 - $168.85 |
|
|
70 |
|
|
7.6 years |
|
$ |
168.85 |
|
|
|
11 |
|
|
$ |
168.85 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
$40.00 - $168.85 |
|
|
822 |
|
|
6.0 years |
|
$ |
90.92 |
|
|
|
562 |
|
|
$ |
72.95 |
|
As of December 31, 2025, the total aggregate intrinsic value of stock options outstanding and stock options exercisable was $60 million and $51 million, respectively.
The grant date fair value of stock options granted was $41.01 per share in 2025 ($67.83 per share in 2024 and $49.62 per share in 2023). The fair value was estimated using the Black-Scholes options pricing model with the following assumptions:
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Exercise price |
|
$ |
109.36 |
|
|
$ |
168.85 |
|
|
$ |
133.03 |
|
Expected dividend yield |
|
|
2.01 |
% |
|
|
1.28 |
% |
|
|
1.53 |
% |
Expected stock price volatility |
|
|
39.29 |
% |
|
|
37.69 |
% |
|
|
37.55 |
% |
Risk-free interest rate |
|
|
4.18 |
% |
|
|
4.52 |
% |
|
|
3.66 |
% |
Expected life (years) |
|
|
6.5 |
|
|
|
6.5 |
|
|
|
6.5 |
|
Stock options granted to employees who are eligible for retirement on the date of the grant are expensed immediately since these awards vest upon retirement from the Company. Retirement, for purposes of vesting in these stock options, means termination of employment after satisfying age and years of service requirements. Similarly, stock options granted to employees who will become retirement-eligible prior to the end of the vesting term are expensed over the period through which the employee will become retirement-eligible. Compensation expense for stock options granted to employees who will not become retirement-eligible prior to the end of the vesting term is recognized on a straight-line basis over the vesting period. Compensation expense for stock options was $5 million in 2025 ($5 million in 2024 and 2023). As of December 31, 2025, unrecognized compensation expense related to stock options was $2 million, which is expected to be recognized over a weighted-average period of 2.0 years.
Restricted Stock Units
Nucor grants restricted stock units (“RSUs”) annually to key employees, officers and non-employee directors. The RSUs granted to key employees and officers vest and are converted to common stock in three equal installments on each of the first three anniversaries of the grant date, provided that a portion of the RSUs awarded to an officer prior to 2018 vest only upon the officer’s retirement. Retirement, for purposes of vesting in these RSUs only, means termination of employment with approval of the Compensation and Executive Development Committee of the Board of Directors after satisfying age and years of service requirements. RSUs granted to a non-employee director are fully vested on the grant date and are payable to the non-employee director in the form of common stock after the termination of the director’s service on the Board of Directors.
RSUs granted to employees who are eligible for retirement on the date of the grant are expensed immediately, and RSUs granted to employees who will become retirement-eligible prior to the end of the vesting term are expensed over the period through which the employee will become retirement-eligible since these awards vest upon retirement from the Company. Compensation expense for RSUs granted to
employees who will not become retirement-eligible prior to the end of the vesting term is recognized on a straight-line basis over the vesting period.
Cash dividend equivalents are paid to holders of RSUs each quarter. Dividend equivalents paid on RSUs expected to vest are recognized as a reduction in retained earnings.
The fair value of an RSU is determined based on the closing price of Nucor’s common stock on the date of the grant.
A summary of Nucor’s RSU activity is as follows (shares in thousands):
|
|
Year Ended December 31, |
|
|||||||||||||||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||||||||||||||
|
|
|
|
|
Grant Date |
|
|
|
|
|
Grant Date |
|
|
|
|
|
Grant Date |
|
||||||
|
|
|
|
|
Fair Value |
|
|
|
|
|
Fair Value |
|
|
|
|
|
Fair Value |
|
||||||
|
|
Shares |
|
|
Per Share |
|
|
Shares |
|
|
Per Share |
|
|
Shares |
|
|
Per Share |
|
||||||
Restricted stock units: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Unvested at beginning of year |
|
|
1,021 |
|
|
$ |
144.89 |
|
|
|
947 |
|
|
$ |
124.89 |
|
|
|
1,003 |
|
|
$ |
98.66 |
|
Granted |
|
|
624 |
|
|
$ |
109.36 |
|
|
|
749 |
|
|
$ |
168.85 |
|
|
|
831 |
|
|
$ |
133.03 |
|
Vested |
|
|
(719 |
) |
|
$ |
132.41 |
|
|
|
(651 |
) |
|
$ |
143.20 |
|
|
|
(873 |
) |
|
$ |
102.79 |
|
Canceled |
|
|
(27 |
) |
|
$ |
139.64 |
|
|
|
(24 |
) |
|
$ |
149.59 |
|
|
|
(14 |
) |
|
$ |
106.76 |
|
Unvested at end of year |
|
|
899 |
|
|
$ |
130.37 |
|
|
|
1,021 |
|
|
$ |
144.89 |
|
|
|
947 |
|
|
$ |
124.89 |
|
Compensation expense for RSUs was $87 million in 2025 ($106 million in 2024 and $88 million in 2023). The total fair value of shares vested during 2025 was $83 million ($110 million in 2024 and $121 million in 2023). As of December 31, 2025, unrecognized compensation expense related to unvested RSUs was $78 million, which is expected to be recognized over a weighted-average period of 1.1 years.
Restricted Stock Awards
The Nucor Corporation Senior Officers Long-Term Incentive Plan (a supplement to the 2014 Plan and the Omnibus Plan, the “LTIP”) provides for the award of shares of restricted common stock at the end of each LTIP performance measurement period at no cost to officers if certain financial performance goals are met during the period. One-third of the LTIP restricted stock award vests upon each of the first three anniversaries of the award date or, if earlier, upon the officer’s attainment of age 55 while employed by Nucor. Although participants are entitled to cash dividends and may vote such awarded shares, the sale or transfer of such shares is limited during the restricted period.
The Nucor Corporation Senior Officers Annual Incentive Plan (a supplement to the 2014 Plan and the Omnibus Plan, the “AIP”) provides for the payment of annual cash incentive awards. An AIP participant may elect, however, to defer payment of up to one-half of an AIP award. In such event, the deferred AIP award is converted into common stock units and credited with a deferral incentive, in the form of additional common stock units, equal to 25% of the number of common stock units attributable to the deferred AIP award. Common stock units attributable to deferred AIP awards are fully vested. Common stock units credited as a deferral incentive vest upon the AIP participant’s attainment of age 55 while employed by Nucor. Vested common stock units are paid to AIP participants in the form of shares of common stock following their termination of employment with Nucor.
A summary of Nucor’s restricted stock activity under the AIP and the LTIP is as follows (shares in thousands):
|
|
Year Ended December 31, |
|
|||||||||||||||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||||||||||||||
|
|
|
|
|
Grant Date |
|
|
|
|
|
Grant Date |
|
|
|
|
|
Grant Date |
|
||||||
|
|
|
|
|
Fair Value |
|
|
|
|
|
Fair Value |
|
|
|
|
|
Fair Value |
|
||||||
|
|
Shares |
|
|
Per Share |
|
|
Shares |
|
|
Per Share |
|
|
Shares |
|
|
Per Share |
|
||||||
Restricted stock units and restricted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Unvested at beginning of year |
|
|
248 |
|
|
$ |
169.36 |
|
|
|
210 |
|
|
$ |
145.55 |
|
|
|
209 |
|
|
$ |
108.55 |
|
Granted |
|
|
267 |
|
|
$ |
133.46 |
|
|
|
421 |
|
|
$ |
187.54 |
|
|
|
414 |
|
|
$ |
171.38 |
|
Vested |
|
|
(312 |
) |
|
$ |
148.12 |
|
|
|
(383 |
) |
|
$ |
175.06 |
|
|
|
(406 |
) |
|
$ |
152.68 |
|
Canceled |
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
— |
|
|
|
(7 |
) |
|
$ |
154.05 |
|
Unvested at end of year |
|
|
203 |
|
|
$ |
154.81 |
|
|
|
248 |
|
|
$ |
169.36 |
|
|
|
210 |
|
|
$ |
145.55 |
|
Compensation expense for common stock and common stock units awarded under the AIP and the LTIP is recorded over the performance measurement and vesting periods based on the anticipated number and market value of shares of common stock and common stock units to be awarded. Compensation expense for anticipated awards based upon Nucor’s financial performance, exclusive of amounts payable in cash, was $41 million in 2025 ($21 million in 2024 and $38 million in 2023). The total fair value of shares vested during 2025 was $42 million ($71 million in 2024 and $69 million in 2023). As of December 31, 2025, unrecognized compensation expense related to unvested restricted stock awards was $6 million, which is expected to be recognized over a weighted-average period of 1.5 years.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 25, 2026 | Showing above |
| 2024 | Feb 27, 2025 | |
| 2023 | Feb 27, 2024 | |
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.